Henlius Heats Up PD-L1 ADC Playground As Pfizer Balks

 
• By Dexter Jie Yan
  
The anti-PD-L1 ADC field is heating up. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D